Skip to content

Contact +44 (0) 20 7060 7474 email us

Research (R&D)

The Future of Contract Research Outsourcing

Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking

Publication Date December 2009
Publisher GBI Research
Product Type Report
Pages 69
ISBN Number not applicable
Product Code GBI00003

Price

£2,330.00
approximately: $3,501 | €2,554

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

GBI Research, the leading business intelligence provider, has released its latest research, "The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking". The research provides key data, information and analysis of the global contract research outsourcing market. The report provides market overview, competitive landscape and market trends information on the contract research outsourcing market. This report provides comprehensive information on the different service models present in the industry, key trends affecting contract research organizations and key analytical content on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, strategic partnerships and service agreements.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:

  • Overview of contract research outsourcing and key reasons why pharmaceutical and biotechnology companies outsource to contract research organizations
  • Comprehensive analysis of the fully-integrated and functional service models of contract research outsourcing
  • Market size (2006-2015) and company share (2008) data for global contract research outsourcing market
  • Qualitative analysis of market drivers, restraints and trends
  • Geographic landscape covering the emerging regions such as Central and Eastern Europe, Latin America, India and China for contract research outsourcing
  • Competitive landscape covering key players Quintiles, Covance, PPD, Charles River Laboratories and PARAXEL International
  • M&A landscape and opportunity analysis of the emerging markets
  • Regulatory landscape of the US and key European countries in the contract research outsourcing market

Reasons to buy

The report will enhance your decision making capability. It will enable you to:

  • Develop key strategies to reduce expenditure on R&D by outsourcing to the contract research organizations
  • Develop a clear knowledge and understanding of how companies use contract research outsourcing to improve drug development productivity
  • Make informed decisions related to contract research outsourcing by building a thorough understanding of the benefits and drawbacks of contract research outsourcing
  • Identify leading contract research outsourcing destinations and the best practices for entering into contract research outsourcing agreements in different countries
  • Identify key players best positioned to take advantage of the emerging market opportunities
  • Make informed decisions related to the M&A activities in the contract research outsourcing market
  • Overcome the regulatory hurdles in the contract research outsourcing market
  • Make more informed business decisions from the insightful and in-depth analysis of the global contract research outsourcing market and the factors shaping it

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Contract Research Outsourcing - Introduction
    • 2.1 GBI Research Report Guidance
  • 3 Contract Research Outsourcing - Overview
    • 3.1 Global Contract Research Outsourcing
      • 3.1.1 The Clinical Research Process
    • 3.2 Outsourcing of Clinical Research and Trial Processes
      • 3.2.1 Clinical Research Outsourcing is Seen as a Solution to Problems Such as Rising Costs or Low Productivity
      • 3.2.2 Strategic Outsourcing Delivers Greater Value by Understanding the Core Competencies of the Vendor and Outsourcing Companies
    • 3.3 Key Reasons for Outsourcing to Contract Research Organizations
      • 3.3.1 Desire to Reduce Costs is a Prime Reason for Contract Research Outsourcing
      • 3.3.2 Contract Research Organizations are Engaged in Reducing Time to Market in Order to Achieve a Competitive Edge
      • 3.3.3 Outsourcing Critical but Resource and Time Intensive Functions such as Data Management Allows Biopharmaceutical Companies to Focus on Core Competencies
      • 3.3.4 Evolving Risk Sharing Agreements Attract Biopharmaceutical Companies to Increase Contract Research Outsourcing
      • 3.3.5 Contract Research Organizations are Helping to Improve Clinical Research Quality Through Better Regulatory Understanding and Keeping Pace with Technological Advances
      • 3.3.6 Small and Medium Biopharmaceutical Companies can Leverage on the Resources of Contract Research Organizations
      • 3.3.7 Biopharmaceutical Companies Benefit from New Technologies that Contract Research Organization Have Access to
  • 4 Contract Research Outsourcing - Service Models
    • 4.1 Contract Research Outsourcing Service Model
      • 4.1.1 Fully Integrated Service Model
      • 4.1.2 Functional Service Model
    • 4.2 Criteria for Selecting a Contract Research Organization
    • 4.3 Early Stage Drug Development Outsourcing
      • 4.3.1 Strategic or Tactical Advantages of Outsourcing
      • 4.3.2 Case Study
    • 4.4 Clinical Stage Drug Development Outsourcing
      • 4.4.1 Strategic or Tactical Advantages of Outsourcing
      • 4.4.2 Case Studies
    • 4.5 Late Stage Development Outsourcing
      • 4.5.1 Strategic or Tactical Advantages of Outsourcing
  • 5 Contract Research Outsourcing - Market Characterization
    • 5.1 The Contract Research Outsourcing Market will Continue to Grow, Driven by the Demand by the Biopharmaceutical Industry
    • 5.2 Key Market Drivers
      • 5.2.1 Increasing R&D Expenditure and Decreasing Productivity in the Biopharmaceutical Industry - Promoting R&D Outsourcing
      • 5.2.2 Stringent Regulations and Complex Clinical Trials Forcing Biopharmaceutical Companies to Leverage on the Contract Research Organizations
      • 5.2.3 Restriction on Pricing and Reimbursement of Drugs - Need for Managing Costs from Earliest Stages of Development
      • 5.2.4 The Increasing Number of Clinical Trials
    • 5.3 Key Market Restraints/ Challenges
      • 5.3.1 Quality Concerns
      • 5.3.2 Economic Recession
    • 5.4 Contract Research Outsourcing - Market Trends
      • 5.4.1 The Number of Services Focusing on the Late Stage Clinical Development is Increasing
      • 5.4.2 The Clinical Research and Trials are Becoming more Globalized
      • 5.4.3 Pharmaceutical Companies are Moving to Strategic Partnerships with Contract Research Organizations
      • 5.4.4 Emerging Tools to Enhance Drug Discovery Process Will be Key Drivers in the Future
    • 5.5 Contract Research Outsourcing - Unmet Needs
      • 5.5.1 High Technology Needs and Integration
      • 5.5.2 Lack of Therapeutic Expertise
      • 5.5.3 Contract Research Organizations are Short of Experienced Research Professionals to Conduct the Clinical Trial Studies
  • 6 Contract Research Outsourcing - Geographical Landscape
    • 6.1 Emerging Regions in the Global Contract Research Outsourcing Market
      • 6.1.1 Latin America
      • 6.1.2 Central and Eastern Europe (CEE)
      • 6.1.3 India
      • 6.1.4 China
  • 7 Contract Research Outsourcing - Regulatory Issues
    • 7.1 Contract Research Organizations are Subject to the Same Regulations as Biopharmaceutical Companies
      • 7.1.1 Regulation in the Drug Discovery Stage
      • 7.1.2 Regulation in the Preclinical Stage
      • 7.1.3 Regulation in the Clinical Trials Stage
    • 7.2 Regulations Governing Outsourcing to Other Regions
  • 8 Contract Research Outsourcing - Competitive Landscape
    • 8.1 Overview
    • 8.2 Market Share Analysis
    • 8.3 Competitive Profiling
    • 8.4 Quintiles Transnational Corp
      • 8.4.1 Snapshot
      • 8.4.2 Business Description
      • 8.4.3 Recent M&A Deals and Strategic Alliances
    • 8.5 Covance Inc
      • 8.5.1 Business Description
      • 8.5.2 Recent M&A Deals and Alliances
    • 8.6 Pharmaceutical Product Development (PPD) Inc
      • 8.6.1 Business Description
      • 8.6.2 Recent M&A Deals and Alliances
    • 8.7 Charles River Laboratories International, Inc
      • 8.7.1 Business Description
      • 8.7.2 Recent M&A Deals and Alliances
    • 8.8 PAREXEL International
      • 8.8.1 Business Description
      • 8.8.2 Recent M&A Deals and Alliances
  • 9 Contract Research Outsourcing - Deals Analysis
    • 9.1 Mergers and Acquisitions
      • 9.1.1 Quintiles Acquires Targeted Molecular Diagnostics
      • 9.1.2 Quintiles Acquires Bio-Trials
      • 9.1.3 PPD Acquired Magen BioSciences
      • 9.1.4 Charles River Laboratories Acquired PPD, Inc.'s Subsidiary Piedmont Research Center for $46m Cash
      • 9.1.5 ICON Acquires Prevalere Life Sciences Inc
      • 9.1.6 ICON Acquires DOCS International
      • 9.1.7 MDS Inc Acquires Molecular Devices Corporation
      • 9.1.8 Kendle Acquires International Clinical Research
      • 9.1.9 PRA International Acquires Pharma Bio-Research
    • 9.2 Strategic Alliances, Service Agreements and Other Deals
    • 9.3 Deals by Year
    • 9.4 Deals by Therapeutic Area
  • 10 Contract Research Outsourcing - Appendix
    • 10.1 Market Definitions
    • 10.2 Abbreviations
    • 10.3 Sources
    • 10.4 Methodology
      • 10.4.1 Coverage
      • 10.4.2 Secondary Research
      • 10.4.3 Primary Research
      • 10.4.4 Expert Panel Validation
    • 10.5 Contact Us
    • 10.6 Disclaimer
  • 1.1 List of Tables
    • Table 1: Drug Development Outsourcing Models, November 2009
    • Table 2: Contract Research Outsourcing Market, Global, Benchmarking Analysis for Top Five Contract Research Organizations, 2008, November 2009
    • Table 3: Major M&A Deals in the Contract Research Outsourcing Market Between 2006-2009
  • 1.2 List of Figures
    • Figure 1: Contract Research Outsourcing Market, Global, Basic Services Provided, November 2009
    • Figure 2: Clinical Research Process, November 2009
    • Figure 3: Contract Research Outsourcing - Reasons for Outsourcing, November 2009
    • Figure 4: Contract Research Outsourcing - Fully Integrated Service Model, November 2009
    • Figure 5: Contract Research Outsourcing - Functional Service Model, November 2009
    • Figure 6: Key Factors Considered for Evaluating and Selecting a Contract Research Organization, November 2009
    • Figure 7: Strategic or Tactical Advantages in Early Stage Drug Development Outsourcing, November 2009
    • Figure 8: Strategic or Tactical Advantages of Outsourcing in the Clinical Stage of the Drug Development Process, November 2009
    • Figure 9: Strategic or Tactical Advantages of Outsourcing in the Late Stage of the Drug Development Process, November 2009
    • Figure 10: Global Contract Research Outsourcing Market Forecasts, 2006-2015
    • Figure 11: Contract Research Outsourcing Market, Global, Market Share by Phase, 2008
    • Figure 12: Comparison of CAGR of R&D Expenditure vs. Turnover for the Top 5 Companies,2003-2008
    • Figure 13: Increasing R&D Expenditure and Decline in NME Approvals by the FDA, 1996-2008
    • Figure 14: Impact of Increasing R&D Expenditure and Lower R&D Productivity in the Pharma/Biotech Industry, November 2009
    • Figure 15: Impact of Changing Regulatory Requirements in the Pharma/Biotech Industry, November 2009
    • Figure 16: Impact due to Pricing and Reimbursement of Drugs in the Pharma/Biotech Industry, November 2009
    • Figure 17: Impact of Increasing Number of Clinical Trials in the Pharma/Biotech Industry, November 2009
    • Figure 18: Impact of Quality Concerns on the Biopharmaceutical Industry, November 2009
    • Figure 19: Impact of Economic Recession on the Biopharmaceutical Industry, November 2009
    • Figure 20: Research and Development Expenditure Split by Phases, 2008
    • Figure 21: Value of Spending in Research and Development by Phases, 2008
    • Figure 22: Average Number of Patients Enrolled Per Site by Geography, 2008
    • Figure 23: Clinical Studies by Region, November 2009
    • Figure 24: Outsourcing to Latin America, November 2009
    • Figure 25: Outsourcing to Central and Eastern Europe (CEE), November 2009
    • Figure 26: Outsourcing to India, November 2009
    • Figure 27: Outsourcing to China, November 2009
    • Figure 28: Drug Development Process and Regulation, November 2009
    • Figure 29: Key Guiding Principles of Good Laboratory Practice, November 2009
    • Figure 30: Key Guiding Principles of Good Clinical Practice, November 2009
    • Figure 31: Global Contract Research Outsourcing Market, Revenue Analysis of Major Contract Research Organizations, 2006-2008
    • Figure 32: Contract Research Outsourcing Market, Global Competitive Analysis of Top 5 Players, 2006-2008
    • Figure 33: Contract Research Outsourcing Market, Market Share of Top Service Providers, 2008
    • Figure 34: Quintiles - Snapshot, November 2009
    • Figure 35: Covance - Snapshot, November 2009
    • Figure 36: PPD - Snapshot, November 2009
    • Figure 37: Charles River Laboratories - Snapshot, November 2009
    • Figure 38: PAREXEL International - Snapshot, November 2009
    • Figure 39: Deals Activity of Top Ten Contract Research Organizations, 2006-2009
    • Figure 40: Global Contract Research Outsourcing Market, Major Deals by Phase, 2006-2009
    • Figure 41: Global Contract Research Outsourcing Market, Major Deals by Year, 2006-2009
    • Figure 42: Global Contract Research Outsourcing Market, Major Deals by Therapeutic Area, 2006-2009
    • Figure 43: GBI Research Methodology